CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer—A Multicenter Analysis

SIMPLE SUMMARY: Low-grade serous cancer (LGSC) accounts for approximately 5% of all ovarian cancers. It is characterized by its high resistance to chemotherapy. Cytoreductive surgery, therefore, is the primary treatment modality for this disease and previous studies have shown that complete removal...

Descripción completa

Detalles Bibliográficos
Autores principales: Wohlmuth, Christoph, Djedovic, Vladimir, Kjaer, Susanne K., Jensen, Allan, Glasspool, Rosalind, Roxburgh, Patricia, DeFazio, Anna, Johnatty, Sharon E., Webb, Penelope M., Modugno, Francesmary, Lambrechts, Diether, Schildkraut, Joellen M., Berchuck, Andrew, Thomsen, Liv Cecilie Vestrheim, Bjorge, Line, Høgdall, Estrid, Høgdall, Claus K., Goode, Ellen L., Winham, Stacey J., Matsuo, Keitaro, Karlan, Beth Y., Lester, Jenny, Goodman, Marc T., Thompson, Pamela J., Pejovic, Tanja, Riggan, Marjorie J., Lajkosz, Katherine, Tone, Alicia, May, Taymaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024456/
https://www.ncbi.nlm.nih.gov/pubmed/35454861
http://dx.doi.org/10.3390/cancers14081954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024456/
https://www.ncbi.nlm.nih.gov/pubmed/35454861
http://dx.doi.org/10.3390/cancers14081954

Ejemplares similares